Suven Life Sciences share news, announcements and annual reports
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Suven Life Sciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995 on BSE, Oct 2003 on NSE
Last close ₹271.75up ₹12.90 (4.98%)BSE ₹271.75
Share price at the NSE close on 2 Nov 2026. Previous close ₹258.85.
2 Nov: open ₹260.10, high ₹275.50, low ₹256.30
52-week range of traded prices to 2 Nov 2026
₹124.11Low, 24 Mar 2026₹403.35High, 1 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,679 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,18,38627.5% delivered
Suven Life Sciences share news and announcements
803 announcements, routine notices left out, newest first. Page 12 of 17.
May 2014
22 May · Results
Apr 2014
Mar 2014
Feb 2014
4 Feb · Updates
Jan 2014
Nov 2013
11 Nov · Results
11 Nov · Updates
Oct 2013
22 Oct · Board Meeting Postponed
Board Meeting to be held on October 29, 2013 to consider un-audited financial results for the second quarter ended September 30, 2013 has been postponed due to non-availability of requisite quorum.
Sep 2013
Aug 2013
13 Aug · Results
5 Aug · Board meeting
To consider, inter alia, and take on record the Un-audited Financial Results for the first quarter ended June 30, 2013.
Jul 2013
Jun 2013
May 2013
27 May · Meeting
Company has fixed Book Closure dates for the Register of members and Share Transfer from August 5, 2013 to August 7, 2013 (both days inclusive) for the purpose of dividend & Annual General Meeting of the Company scheduled to be held on August 13, 2013.14 May · Dividend
Board of Directors of the company at its meeting held on May 14, 2013 has recommended dividend Re.0.30 paisa per equity share of face value of Re.1/- each (30%) for the financial year ended March 31, 2013.14 May · Results
Apr 2013
Mar 2013
Feb 2013
12 Feb · Updates